Wednesday
Oct122016
NCT02947854
An Open-label, Phase I/Proof of Principle, Dose Escalation Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation (PCI) of Antigen/Adjuvant in Healthy Male/Female Subjects
Condition: Healthy Volunteers
Sponsor: PCI Biotech
Phase 1